Healthcare provider profile · identity verified

Mary Elizabeth Devries, APRN, NP

Nurse Practitioner · CARLINVILLE, IL · NPI 1457869232

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Tramadol Hcl	Tramadol Hcl	294	61
Atorvastatin Calcium	Atorvastatin Calcium	219	62
Omeprazole	Omeprazole	198	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	168	36
Levothyroxine Sodium	Levothyroxine Sodium	167	42
Metformin Hcl	Metformin Hcl	155	36
Furosemide	Furosemide	151	37
Metoprolol Tartrate	Metoprolol Tartrate	139	39
Pantoprazole Sodium	Pantoprazole Sodium	126	42
Tamsulosin Hcl	Tamsulosin Hcl	125	38
Lisinopril	Lisinopril	124	31
Gabapentin	Gabapentin	122	26
Escitalopram Oxalate	Escitalopram Oxalate	113	30
Prednisone	Prednisone	111	74
Fluticasone Propionate	Fluticasone Propionate	110	42
Metoprolol Succinate	Metoprolol Succinate	108	30
Alprazolam	Alprazolam	98	23
Meloxicam	Meloxicam	93	26
Clopidogrel	Clopidogrel Bisulfate	87	21
Lorazepam	Lorazepam	85	17
Amlodipine Besylate	Amlodipine Besylate	82	31
Trazodone Hcl	Trazodone Hcl	77	18
Naproxen	Naproxen	76	34
Albuterol Sulfate Hfa	Albuterol Sulfate	74	34
Losartan Potassium	Losartan Potassium	72	16
Montelukast Sodium	Montelukast Sodium	70	17
Sertraline Hcl	Sertraline Hcl	70	20
Potassium Chloride	Potassium Chloride	69	17
Cephalexin	Cephalexin	65	53
Glipizide	Glipizide	63	13
Rosuvastatin Calcium	Rosuvastatin Calcium	62	21
Triamcinolone Acetonide	Triamcinolone Acetonide	62	33
Allopurinol	Allopurinol	60	16
Alendronate Sodium	Alendronate Sodium	58	20
Carvedilol	Carvedilol	58	19
Simvastatin	Simvastatin	58	19
Azithromycin	Azithromycin	56	45
Pregabalin	Pregabalin	56	suppressed
Glimepiride	Glimepiride	55	12
Benazepril Hcl	Benazepril Hcl	52	11
Famotidine	Famotidine	50	14
Paroxetine Hcl	Paroxetine Hcl	49	suppressed
Citalopram Hbr	Citalopram Hydrobromide	48	11
Hydrochlorothiazide	Hydrochlorothiazide	45	13
Eliquis	Apixaban	44	16
Ozempic	Semaglutide	44	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	43	12
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Atenolol	Atenolol	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	13
Pravastatin Sodium	Pravastatin Sodium	33	12
Buspirone Hcl	Buspirone Hcl	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	12
Levetiracetam	Levetiracetam	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	22
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	19
Caplyta	Lumateperone Tosylate	27	suppressed
Ibuprofen	Ibuprofen	27	11
Spironolactone	Spironolactone	27	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Olanzapine	Olanzapine	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	12
Ondansetron Odt	Ondansetron	23	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Finasteride	Finasteride	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Fluconazole	Fluconazole	18	16
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Humalog	Insulin Lispro	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Baclofen	Baclofen	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Larin Fe	Norethindrone-E.Estradiol-Iron	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nystatin	Nystatin	12	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	12	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Diazepam	Diazepam	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Sodium Oxybate	Sodium Oxybate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error